Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7535 in Type 2 Diabetes Mellitus (Metformin Inadequate Control)
CTR20230393Phase 2Completed
- Sponsor
- Shandong Shengdi Pharmaceutical
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7535 in type 2 diabetes mellitus (T2DM), sponsored by Shandong Shengdi Pharmaceutical. Started Feb 2023; status: completed.
02
Drugs
HRS-7535
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20230393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230393.